Aldesleukin

Also known as: IL-2 Interleukin-2 precursor T-cell growth factor (TCGF)

Active ingredient description

Aldesleukin, a lymphokine, is produced by recombinant DNA technology and acts as a regulator of the immune response. The biological activities of aldesleukin and native human IL-2, a naturally occurring lymphokine, are comparable. The administration of aldesleukin in murine tumour models has been shown to reduce both tumour growth and spread. The exact mechanism by which aldesleukin-mediated immunostimulation leads to antitumour activity is not yet known.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Aldesleukin
L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AC Interleukins
Discover more medicines within L03AC01

Medicines

Aldesleukin is the active ingredient of these drugs:

Drug
Countries

Austria Brazil Canada France Netherlands

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique ingredient identifier (UNII)

M89N0Q7EQR - ALDESLEUKIN

SNOMED-CT

386917000 - Aldesleukin (substance)